XT
ERNA icon

XTX Topco’s Eterna Therapeutics ERNA Stock Holding History

XTX Topco’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,174
Closed -$10.8K – 4289
2026
Q1 		$10.8K Buy
+2,174
New +$34.7K ﹤0.01% 3674
2025
Q2 		– Sell
-110
Closed -$7.37K – 2572
2025
Q1 		$7.37K Sell
110
-45
-29% -$5.55K ﹤0.01% 2279
2024
Q4 		$17.1K Buy
+155
New +$42K ﹤0.01% 2065

Other funds holding ERNA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tradewinds Capital Management Bellingham, Washington $563M AUM 41.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

XTX Topco's ERNA Position: Q2 2026 in Review

XTX Topco sold out of Eterna Therapeutics (ERNA) in Q2 2026, closing a stake of 2,174 shares — an estimated $10.8K sold.

XTX Topco first reported a position in ERNA in Q4 2024 and held it in 3 quarters. The position peaked at $17.1K in Q4 2024. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2026.

  • XTX Topco reported no remaining Eterna Therapeutics position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 2,174 Eterna Therapeutics shares in Q2 2026, an estimated $10.8K.
  • XTX Topco first reported a position in Eterna Therapeutics in Q4 2024 and held it in 3 quarters.
  • XTX Topco's Eterna Therapeutics position peaked at $17.1K in Q4 2024.
  • 9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.